Comments
Lupin on Tuesday announced the completion of the Good Manufacturing Practices (GMP) inspection of its finished products manufacturing facility (Unit-1) at Mandideep, by the French National Agency for Medicines and Health Products Safety (ANSM).
The inspection was conducted between April 8 and April 12. The ANSM inspection closed with no critical or major observations, Lupin said. Shares of Lupin closed 0.76 per cent lower at ₹750.90 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.